[HTML][HTML] Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

C Ma, MD Sacco, B Hurst, JA Townsend, Y Hu, T Szeto… - Cell research, 2020 - nature.com
A new coronavirus SARS-CoV-2, also called novel coronavirus 2019 (2019-nCoV), started
to circulate among humans around December 2019, and it is now widespread as a global …

Expedited approach toward the rational design of noncovalent SARS-CoV-2 main protease inhibitors

…, F Zhang, X Zhang, M Ba, T Szeto… - Journal of medicinal …, 2021 - ACS Publications
The main protease (M pro ) of SARS-CoV-2 is a validated antiviral drug target. Several M pro
inhibitors have been reported with potent enzymatic inhibition and cellular antiviral activity, …

Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and a FlipGFP-based reporter assay

…, JA Townsend, Y Hu, X Meng, T Szeto… - ACS central …, 2021 - ACS Publications
The papain-like protease (PL pro ) of SARS-CoV-2 is a validated antiviral drug target.
Through a fluorescence resonance energy transfer-based high-throughput screening and …

Rational design of hybrid SARS-CoV-2 main protease inhibitors guided by the superimposed cocrystal structures with the peptidomimetic inhibitors GC-376, telaprevir …

…, Y Hu, C Ma, X Meng, F Zhang, T Szeto… - ACS Pharmacology & …, 2021 - ACS Publications
SARS-CoV-2 main protease (M pro ) is a cysteine protease that mediates the cleavage of
viral polyproteins and is a validated antiviral drug target. M pro is highly conserved among all …

Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses

Y Hu, C Ma, T Szeto, B Hurst, B Tarbet… - ACS infectious …, 2021 - ACS Publications
As the COVID-19 pandemic continues to unfold, the morbidity and mortality are increasing
daily. Effective treatment for SARS-CoV-2 is urgently needed. We recently discovered four …

[HTML][HTML] Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture

Y Hu, C Ma, T Szeto, B Hurst, B Tarbet, J Wang - bioRxiv, 2020 - ncbi.nlm.nih.gov
As the COVID-19 pandemic continues to fold out, the morbidity and mortality are increasing
daily. Effective treatment for SARS-CoV-2 is urgently needed. We recently discovered four …

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease (preprint)

C Ma, MD Sacco, B Hurst, JA Townsend, Y Hu, T Szeto… - 2020 - pesquisa.bvsalud.org
A novel coronavirus SARS-CoV-2, also called novel coronavirus 2019 (nCoV-19), started to
circulate among humans around December 2019, and it is now widespread as a global …

Prevalence of ocular manifestations and visual outcomes in patients with herpes zoster ophthalmicus

SKH Szeto, TCY Chan, RLM Wong, ALK Ng, EYM Li… - Cornea, 2017 - journals.lww.com
Purpose: To investigate the prevalence of ocular manifestations and visual outcomes in
patients with herpes zoster ophthalmicus (HZO). Methods: Consecutive cases diagnosed with …

[BOOK][B] Dynamic traffic assignment: formulations, properties, and extensions

WY Szeto - 2003 - search.proquest.com
… Representing traffic dynamics as side constraints explicitly is cumbersome and makes
solutions difficult to be obtained efficiently (Lo and Szeto, 2002a). Modeling the traffic-flow …

A Student Perspective on the Effectiveness of PASS in Seminar Courses: A Mixed-Method Study

WM Szeto, KM Li, VJ Wu, IKT Wong… - Journal of Peer …, 2022 - ro.uow.edu.au
The General Education Foundation (GEF) Programme, consisting of two seminar courses,
namely “In Dialogue with Humanity” and “In Dialogue with Nature,” has been a common core …